Eversense® Non-adjunctive Use Post Approval Study
Eversense® Non-adjunctive Use Post Approval Study
Active, not recruiting · NCT04836546 · Registry updated 2025-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Eversense® Non-adjunctive Use Post Approval Study | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus, type 2 diabetes mellitus | Active, not recruiting | Not applicable | 2025-08-13 | NCT04836546 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Senseonics, Inc. | 3 |
23 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.